GAINSWave® is the premium brand in low-intensity shockwave therapy used to treat men with erectile dysfunction and increase performance.
A Way to Maintain Lifelong Healthy Sexual Function
GAINSWave is a therapy that can assist men in maintaining lifelong healthy sexual function. Providers report a high, double-digit success rate (greater than 75%) with their patients. Some patients notice an improvement the day of their first treatment. Others get the best result with 6-12 treatment sessions, depending on the severity of their erectile dysfunction.
How GAINSWave Works
Research scientists postulate that the low-intensity radial acoustic sound waves stimulate cell division and promote neovascularization – developing new capillaries and unblocking blood vessels within the penile tissues. This process is believed to be one of the triggers that promote blood flow and better erection quality. The shockwaves repair and stimulate the growth of new blood vessels and remove micro-plaque that restricts penile hemodynamics.
High-Frequency, Low-Intensity Radial Sound Waves
A Natural, Long-lasting Solution for ED
The shear stress created by the low-intensity sound waves does all this intracellular mitosis without actually injuring the tissue. GAINSWave Li-ESWT is the first non-surgical, non-medical therapy that offers men an organic solution for ED as well as enhanced and sustained erection quality.
Efficacy & Safety
The science and efficacy of GAINSWave is based on clinical studies over the past 15 years showing a greater than 75% success rate in treating Erectile Dysfunction through vasculogenesis as induced by Li-ESWT.
To date, more than 60 clinical studies have shown GAINSWave to be a safe & effective treatment option for ED.
With more than 40 clinical studies to support the safety and efficacy of Li-ESWT, the future of GAINSWave ED Therapy is positioned to be a highly viable alternative for men seeking a more natural way to combat erectile dysfunction as well as an ongoing maintenance therapy for sustained sexual performance.